RTsafe is a medical technology company that has developed a unique approach to quality assurance that significantly enhances the safety and accuracy of radiotherapy for cancer and other medical conditions.
We combine proven expertise in medical physics with highly accurate 3D printing technology to create pseudo-in-vivo dosimetry phantoms towards End-to-End commissioning, benchmarking and quality assurance in SRS, IMRT, VMAT and SBRT applications.
The anatomically accurate effigies enable medical professionals to plan more precise treatment interventions and help radiotherapy technology innovators to fine-tune their products. The result is more effective therapy, reduced risk and better patient outcomes.
We also offer data analytics services and polymer gel dosimeters for radiotherapy. Our initial systems are focused on the treatment of brain tumours and head and neck cancers but we are actively pursuing application of the principle to other parts of the body. Moreover, our team also specializes in advanced QA for MRI scanners towards enhancing their performance for Radiation Oncology needs.
RTsafe innovating patient-specific QA solutions are Patent Pending (PCT/US2014/054838)